Edges in Network
Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | CLEC2B |
Upstream (Parents) |
---|
(<<) AIF1 → CLEC2B |
(<<) DCN → CLEC2B |
(<<) MNDA → CLEC2B |
(<<) DSE → CLEC2B |
Downstream (Children) |
---|
CLEC2B → WIPF1 (>>) |
CLEC2B → PPP1R9A (>>) |
CLEC2B → NRBF2 (>>) |
CLEC2B → CYP2A6 (>>) |
CLEC2B → AIF1 (>>) |
CLEC2B → CBR1 (>>) |
CLEC2B → PLCL2 (>>) |
CLEC2B → AOAH (>>) |
CLEC2B → HEPH (>>) |
CLEC2B → MMP19 (>>) |
CLEC2B → GLIPR1 (>>) |
CLEC2B → CLEC4A (>>) |
CLEC2B → DNAI1 (>>) |
CLEC2B → MNDA (>>) |
CLEC2B → MAGEC2 (>>) |
CLEC2B → RPL35A (>>) |
CLEC2B → HOPX (>>) |
CLEC2B → LY96 (>>) |
CLEC2B → SAMSN1 (>>) |
CLEC2B → SLC1A3 (>>) |
CLEC2B → RTN2 (>>) |
CLEC2B → RGS2 (>>) |
CLEC2B → FABP5L2///FABP5L7///FABP5 (>>) |
CLEC2B → NT5E (>>) |